ABSTRACT
Experimental studies in food animal species showed the potential 80 transmissibility of BSE to a range of alternative hosts [8] and it became clear 81 that the small ruminant population had been potentially exposed to infection 82 by dissemination through concentrate feed which may have contained 83 contaminated meat and bone meal, implicated as the origin of the BSE 84 epidemic in cattle [9] . 85
Experimental studies in sheep demonstrated that disease can result from oral 86 challenge with cattle BSE [10] and, once established, it can transmit naturally 87
[11]. In addition, the biological properties of the resulting ovine BSE in 88 laboratory models indicate a potentially enhanced virulence for other species 89 including man [12, 13] . to enable the discrimination of BSE from classical scrapie in these samples. 96
The phenotype of experimental ovine BSE [17] bears a clear resemblance to 97 naturally-occurring scrapie, which is endemic in many sheep populations. 98
However, there are some subtle differences in the biochemical signatures of 99 these diseases. The disease-specific isoform (PrP Sc ), of the normal host 100 protein (PrP C ) is the target for all current TSE biochemical diagnostic tests. 101
Depending on the TSE isolate, e.g. BSE or one of the various forms of 102 scrapie, there are differences in the molecular location of protease K (pK) 103 cleavage sites, and/or relative pK sensitivity. These differences, as visualisedby comparing the relative binding of antibodies against various epitopes 105 around these PK cleavage sites, form the basis of the discriminatory tests 106 currently listed in the regulations, which use either immunohistochemistry 107 (IHC) [18] Western blot (WB) [19, 20] or ELISA [21] formats. 108
In the absence of identified, naturally-occurring ovine BSE, the development 109 and evaluation of the discriminatory tests which form the basis of the current 110 EU statutory requirements was based on panels of samples comprising 111 naturally-occurring classical scrapie, experimentally induced ovine BSE and 112 bovine BSE all of which were demonstrated to be readily distinguishable by 113 these tests [22] . 114
The only experimental study that has been undertaken [23] , suggests that the 115 picture with co-infection in sheep is complicated; the WB and IHC data from 116 central nervous system (CNS) tissues resemble classical scrapie, while in the 117 lymphoreticular system (LRS) they may resemble either classical scrapie or 118 BSE. Subsequent bioassay using two transgenic models (tg110, a line which 119 overexpresses bovine PrP on a null murine PrP background [24] and tg338, a 120 line that overexpresses a VRQ allele of the ovine PrP on a null murine PrP 121 background [25] ) has shown that both BSE and scrapie can be identified by 122 bioassay from the brains of these sheep despite only a classical scrapie signal 123 being detectable on initial screening with WB and IHC [23] . These two 124 transgenic mouse lines, used in combination, are widely accepted to be a 125 robust approach to biological discrimination, because the ovinised line would 126 preferentially propagate scrapie isolates, and the bovinised line would 127 preferentially propagate BSE. They are endorsed by the EU Reference 128 testing in the context of EU regulation 36/2005 (http://www.tse-lab-130 net.eu/documents/tse-oie-rl-handbook.pdf). 131
Although not a widely reported occurrence, there is evidence that animals can 132 be naturally co-infected with atypical and classical scrapie [26] and 133 experimentally with BSE and scrapie [23, 27] 
MATERIALS AND METHODS 158

Materials 159
Experimentally generated ovine classical BSE [17] and four different naturally 160 occurring scrapie isolates which had been characterised pathologically, 161 biochemically and biologically, were sourced (see Table 1 The sample panels were provided 'blinded' to teams in the APHA (for 175 discriminatory Western blotting) and CEA laboratories (for discriminatory 176 ELISA), and both laboratories were asked to provide an initial interpretation of 177 'BSE-like' or 'not BSE-like' before samples were de-coded; samples were alsoprovided to ADAS/University of Nottingham for sPMCA analysis, and were 179 similarly interpreted before decoding. 180
All the neat sources used to prepare the panel were selected for bioassay in 181 transgenic mice, together with the mixture with the highest undetectable 182 percentage of BSE and the mixture containing 1% BSE from each 183 scrapie/BSE combination. For animal bioassays, a bovinised (tg110) and an 184 ovinised (tg338) mouse line were used. A total of 24 assays were performed. 185 186 187
Discriminatory Western blot 188
The samples were subjected to discriminatory Western immunoblotting using 189 the APHA BioRad-Hybrid Western blot method as described in detail in the 190 
Discriminatory ELISA 213
The samples were tested in duplicate, using the discriminatory ELISA method 214 that has been described in detail elsewhere [21] . This method treats each 215 sample with one of two different PK digestion protocols (mild and stringent), 216
and expresses the subsequent differences in antibody binding as a ratio. This 217 ratio is further normalised against the BSE control sample in each assay run. 218
Three internal controls were included: one classical scrapie sample (highly PK 219 resistant, normalised ratio inferior to 0.3), an unusual scrapie sample 220 previously reported [21] to give an 'intermediate' result (PK resistant, 221 normalised ratio comprised between 0.3 and 0.7) and an experimental BSE 222 sample (PK sensitive, normalised ratio comprised between 0.7 and 1.3). 223
According to these values, the blinded samples were categorised as 'scrapie', 224 (Table 1) , and these were 235 normalised for the ovine BSE sample. 236
237
Animal bioassays 238
All intracerebral inoculations were carried out under general anaesthesia, and 239 Each inoculum (10% w/v brain homogenate in normal saline) was used to 244 challenge 10 tg110 and 10 tg338 mice intracerebrally (20µl per mouse). The 245 mice were allowed to develop TSE disease and were euthanized when they 246 reached terminal disease stage, or due to other welfare reasons. At post 247 mortem each brain was sectioned parasagitally; 2/3 was fixed and 248 subsequently processed for histology and immunohistochemistry whilst the 249 remaining 1/3 was kept frozen. 250
All samples were examined for the presence of TSE specific vacuolation in 251 H&E slides and for PrP Sc detection using immunohistochemistry with the 252 polyclonal antibody Rb486 according to standard methodology as previously 253 described [34] .Discriminatory sPMCA 256 257
Following completion of this ring trial and bioassay, a potentially discriminatory 258 sPMCA method became available. This method, which is described in detail 259
elsewhere [32] , uses five sPMCA rounds with AHQ/AHQ and VRQ/VRQ 260 sheep brain homogenates as the substrates being used in alternate rounds, 261 followed by PK digestion and visualisation in WB using the monoclonal 262 antibody (mAb) SHa31. This method selects for the amplification of BSE, but 263 not scrapie. 264
Amplified products that are detected in WB are then additionally probed 265 separately by both P4 and SHa31 antibodies in order to confirm BSE status. 266
A panel of original aliquots from this comparative study was supplied, blinded, 267 for testing (Panel 1), then, following initial results Panel 2, generated from the 268 original sources, and extending the dilution range of the ovine BSE to 269 1:10,000, was also tested 'blind'. 270
271
RESULTS
273
Estimated PrP res concentration in the brains of the sources that contributed to 274 the mixtures 275 276
The PrP res concentration in the brains of the sources that contributed to the 277 mixtures is shown in Table 1 . There was less than 1 log difference between 278 the concentration of PrP res in the ovine BSE source and each of the scrapie 279 sources. Assuming that PrP res is a reliable indicator for infectivity, the ratios of 280 BSE relative to scrapie in the series of mixtures used in this study is accurate 281 within 0.27-0.63 logs depending on the classical scrapie source. With the 282 exception of the VRQ/VRQ classical scrapie source, the PrP res concentration 283 in the BSE source was lower compared to the other scrapie sources.Therefore, with the exception mentioned above, in the mixtures of scrapie 285 sources with BSE the concentration of PrP res attributed to scrapie was higher 286 than that indicated by the percentage ratio of the scrapie source in the 287
mixture. 288 289
Discriminatory Western blot 290
The WB results for each sample were recorded using the following criteria; 291 high or low molecular migration with the core antibody (SHa31); strong, 292 medium, weak or negative with the N-terminal antibody (P4) and a description 293 of either classic 3 band or atypical profile for each antibody. Using the 294 combination of results, each sample was assigned a concluding result of BSE, 295 scrapie, atypical scrapie or a description of combined TSE types. 296
Representative descriptions for 14 blinded samples are presented in Table 2 , 297 with corresponding Western blots shown in Fig 1. 
299
Western blotting could consistently detect BSE present within a mixture with 300 scrapie when it was present as 50% of the mixture (Table 3) . 301
302
Discriminatory ELISA 303
The ELISA method could consistently detect BSE when mixed with scrapie 304
when it was present as 99% of the mixture (Table 3) . However the results vary 305 depending on the scrapie strains. BSE was detected when it was present as 306 75% of the mixture (for classical scrapie VRQ/VRQ and ARQ/ARQ), 90% 307 (classical scrapie 1-4-7 ARQ/ARQ) or 99% (atypical scrapie). When the data 308 are unblinded, and the ELISA results grouped by scrapie type (Figure 2 ) it can 309 be seen that this apparent inability to detect BSE is partly due to therestrictions of having a numerical result and cut-offs. There is no qualitative 311 data to aid interpretation of 'intermediate' cases. 312 313 A summary of the ability of the biochemical tests to discriminate BSE in the 314 presence of scrapie, at a ratio of 1% to 99% (Panel 1) when the samples are 315 blinded, is presented in Table 3 . Different isolates resulted in different 316 discriminatory thresholds, which were different between the tests. For 317 example, BSE could be detected at very low levels against a background of 318 atypical scrapie in the WB, but the BSE signal was masked by small amounts 319 of atypical scrapie when present as a mixture in the ELISA. 320
321
Bioassay 322
323
Mixtures of BSE with VRQ/VRQ or ARQ/ARQ classical scrapie 324
Both tests, WB and ELISA, failed to identify the presence of BSE in the 325 dilution series when its ratio in the mixture with VRQ/VRQ classical scrapie 326 dropped below 50% (Table 3) . Therefore the inoculum just below the cut-off 327 point (25% BSE ratio relative to scrapie) and the inoculum with the lowest 328 BSE ratio relative to scrapie (1% BSE) were subjected to bioassays. WB and 329 ELISA also failed to identify the presence of BSE when the ratio of BSE to 330 ARQ/ARQ classical scrapie was below 25% (Table 3) . Therefore the inocula 331 with 10% and 1% BSE concentration relative to scrapie were subjected to 332
bioassays. 333
In tg338 mice the scrapie agents isolated from both classical scrapie sources 334 were indistinguishable, with very short incubation periods -69.5 and 75.5 335 mean dpi for VRQ/VRQ and ARQ/ARQ scrapie isolates respectively ( Figures3A and 4A) , similar lesion profiles ( Figures 3B and 4B ) and similar brain 337 distribution of PrP Sc types as assessed by IHC (data not shown). 338
All tg338 mice that were challenged with BSE succumbed to TSE 624 dpi or 339 later ( Figure 3A) . In contrast, inoculation of tg338 mice with BSE mixed with 340 either the VRQ/VRQ or the ARQ/ARQ classical scrapie sources produced 341 incubation periods less than 90 dpi that were compatible with those produced 342 by the respective scrapie sources alone ( Figures 3A and 4A ). These data 343
indicate that the component isolated in the mice from the BSE mixtures with 344 VRQ/VRQ or ARQ/ARQ classical scrapie only had classical scrapie 345
properties. The vacuolation lesion profiles alone were not conclusive because 346 the VRQ/VRQ and the ARQ/ARQ classical scrapie, and BSE profiles were not 347 dissimilar enough to allow unequivocal interpretation, although the mixtures 348 did align more closely with the classical scrapie profiles produced by the 349 100% scrapie sources ( Figures 3B and 4B) . profiles from the tg110 mice ( Figures 3C and 4C) further support the 360 conclusion that the isolated agent had only BSE properties although it was notpossible to construct lesion profiles from either scrapie source due to the lack 362 of sufficient clinically positive mice diagnosed with TSE. 363 364
1-4-7 ARQ/ARQ classical scrapie and ovine BSE 365 366
Both tests failed to identify the presence of BSE in the dilution series when its 367 concentration in the mixture dropped below 50% (Table 3) . Therefore the 368 inoculum just below the cut off point (25% BSE ratio relative to scrapie) and 369 the inoculum with 1% BSE ratio relative to scrapie were subjected to 370
bioassay. 371 Figure 4A shows that tg338 mice challenged with either of these mixtures 372 succumbed to disease with incubation periods that were compatible with the 373 incubation periods produced by the scrapie source alone, indicating that the 374 agent isolated from the 25% and 1% BSE mixtures was the scrapie 375 component. The lesion profiles are not conclusive because the ARQ/ARQ 376 scrapie and BSE profiles are indistinguishable ( Figure 5B) . 377
The incubation periods of tg110 mice challenged with the 1-4-7 classical 378 scrapie isolate were relatively shorter than the incubation periods caused by 379 BSE in this mouse line ( Figure 5A ). The incubation periods produced by the 380 25% and 1% BSE mixture in this mouse line were aligned with the incubation 381 periods produced by the 1-4-7 ARQ/ARQ classical scrapie source ( Figure 5A) . 382
Lesion profiles concur with this interpretation as the lesion profiles produced 383
by the mixtures align with the lesion profile of the 1-4-7 classical scrapie whilst 384 BSE produces a distinct separate profile ( Figure 5C ). 385 386 Tg110 mice challenged with either the scrapie or the BSE source succumbed 387 to disease with relatively short incubation periods, therefore the miceinoculated with the mixtures were further compared to those challenged with 389 the original sources using immunohistochemistry (IHC) (Figure 6) . 390 Tg110 mice challenged with the 1-4-7 classical scrapie source showed a 391 pattern characterised by intraneuronal and fine punctate PrP Sc deposits in the 392 neuropil; when aggregates were present they were distinct, well demarcated 393 and ovoid ( Figure 6A ).
BSE challenged tg110 mice also showed 394 intraneuronal PrP Sc but the neuropil was populated with diffuse granular 395 deposits, coalescing aggregates and plaque-like formations ( Figure 6B ). In 396 addition to the IHC attributes associated with the 1-4-7 classical scrapie 397 pattern, tg110 mice challenged with either mixture additionally showed 398 features that were associated with the BSE-induced pattern ( Figures 5C and  399   5B ). This BSE associated pattern also appeared to be more extensive in the 400 mice that were challenged with the 25% BSE mixture compared with the mice 401 that received the 1% BSE mixture. 402
Although the incubation periods and the lesion profiles, particularly those 403 generated by mice that were inoculated with 25% BSE mixture, suggest that 404 the BSE agent did not propagate selectively in the tg110 mice, it was still 405 possible to identify the BSE component reliably in the Tg110 mice using IHC. 406
407
Atypical scrapie and ovine BSE 408 409
Both WB and ELISA failed to identify the presence of BSE in the dilution 410 series when its concentration in the mixture dropped below 10% (Table 3) . 411
Therefore the inoculum with 1% BSE concentration relative to scrapie was 412 subjected to bioassays. 413
The incubation period data in tg338 indicate that the agent isolated from these 414 mixtures was compatible with the agent isolated from the atypical scrapiesource; in tg110 mice the incubation period data indicate that agent isolated 416 from the mixtures was compatible with the agent isolated from the BSE source 417 ( Figure 7A ). The lesion profiles from tg338 ( Figure 7B ) and tg110 mice (Figure  418 7C) provide further support to the incubation period data although it was not 419 possible to construct lesion profiles from the scrapie source in tg110 as all of 420 the mice challenged with this source were TSE negative. 421
422
Discriminatory sPMCA 423 424
The original panel of 33 samples (Panel 1) were all correctly reported as 'BSE 425 present', with the correct exception of the un-mixed scrapie samples ( Table  426 3). The analysis of Panel 2 gave identical results for the 1% to 99% mixtures. 427 sPMCA also correctly reported the presence of BSE in all samples in which 428 BSE was diluted to 0.1%. BSE was also successfully detected in one sample 429
where it was diluted to 0.01% with atypical scrapie (Figure 8) . 430
431
Discussion
433
Co-infection studies in animals using mixtures of known infectious titre remain 434 the hypothetical ideal for this type of study, but for several reasons such 435 studies are not necessarily as appropriate as they might appear on initial 436 consideration. The observed titre of a TSE isolate is not an absolute measure 437 of the infectivity of that isolate, but is also affected by the susceptibility of the 438 host, which may differ for different isolates. For example, some scrapie strains 439 that readily infect sheep and transgenic mouse models do not cause disease 440 in conventional inbred mouse lines [2, 33] . Therefore it is unwise to assume 441 that two isolates with similar observed levels of infectivity in any one model 442 will necessarily have the same infectivity potential in other species, or indeedin animals of different genotypes. Equally, PrP res concentration cannot be 444 considered to be a consistent proxy for the level of infectivity in an isolate [37] . 445
The interaction of strains either in vitro or within a single host is also very 446 poorly understood. If strain properties are conferred by tertiary molecular 447 structure, then mixing isolates together might affect the ability of a strain to 448 infect a host either in an inhibitory or potentiating way. This may also affect 449 tests applied to a sample with both isolates represented. However, the data 450 from this study demonstrate that this is not the case, at least with the BSE and 451 scrapie combinations used; all tests and models, except the sPMCA, could 452 correctly classify both of the strains contributing to each of the mixtures, 453
including the successful isolation, in mice, of all the component isolates of 454 each mixture, with retention of the biological phenotypes of the unmixed 455
controls. 456
The bioassay data, particularly from the bovinised mice, also suggest that if 457 sheep are exposed to both BSE and scrapie, the two agents will most likely 458 propagate as independent entities according the dynamics of titre, time of 459 exposure to each agent and ovine PrP genotype. Therefore exposure to both 460 agents is unlikely to result in a novel agent with previously undetected 461 biochemical or biological properties, although this possibility should always be 462 considered when a new or unusual isolate is identified. Under these 463 circumstances exposure to both agents would give rise to a mixture in which 464 BSE can be detected with the current biochemical and biological tests 465 provided that the titre of scrapie is not overwhelming. The data also show that 466 the choice of diagnostic test, and which scrapie strain is present, both dictate 467 the level of scrapie that "overwhelms" the detection of BSE. For BSE mixedwith atypical scrapie the presence of 10% scrapie masked BSE detection by 469 ELISA whereas, at the other extreme, BSE mixed with atypical scrapie and 470 detected by WB required the presence of above 90% scrapie to mask BSE. 471
Additional unknowns, if trying to use an in vivo challenge model to recreate 472 possible co-infection, are the age of the animal at challenge, the order in 473 which the challenges occur, and possibly the length of time between the 474 challenges [38, 39, 40] . 475
The main purpose of this study was to attempt the identification of the BSE 476 component of the mixture by using the approved discriminatory tests (EU 477 regulation 36/2005), followed by discriminatory bioassay in tg338 mice to 478 selectively propagate the scrapie strains, and tg110 mice to selectively 479 propagate the BSE agent, in mixtures in which the identifiable biochemical 480 signature of BSE has been lost or obscured. We conclude that the 481 biochemical rapid tests can discriminate BSE in the presence of scrapie to 482 varying degrees depending on the scrapie source, but this variation does not 483 appear to be attributable to the amount of PrP res . The WB was more reliable 484 than ELISA in discriminating BSE in the presence of scrapie, regardless of the 485 scrapie isolate. 486
The bioassay was capable of resolving cases of co-infection even where BSE 487 represented just 1% of the total TSE infectivity. In order to achieve this, 488 bioassay systems should include a bovinised mouse line that favours 489 propagation of BSE over scrapie, and an ovinised line with complementary 490 properties, i.e. a line that preferentially facilitates the propagation of scrapie 491 prions over the BSE agent. In addition to the ability to identify BSE in mixed 492 infections, bioassay continues to be the only validated method available thatenables the comprehensive phenotypic characterisation of an unknown 494
isolate. 495
It is probably not possible to source 'ideal' mouse lines with the above 496 properties particularly as classical scrapie consists of various strains with 497 widely variable properties. However, the selected mouse lines (tg338 and 498 tg110) are as close as possible to that ideal situation and could be used in 499 combination to resolve co-infection cases in a surveillance context if they 500
arise. In addition, IHC may be useful to resolve a small proportion of 501 bioassays in which the relative mouse line susceptibility is not, by itself, 502
conclusive. 503
Within this study, the new discriminatory sPMCA approach was the only in 504 vitro method which consistently detected BSE when it was present in these 505 mixtures, even at very low concentration (down to 0.1%). This sensitivity could 506
potentially be exploited to screen pooled ovine TSE brain samples for the 507 presence of BSE, greatly increasing the throughput, and decreasing the costs 508 of such screening programmes in the future. When the purpose of an 509 investigation is solely to determine the presence or absence of BSE (as 510 opposed to characterising whatever is in the isolate), this assay would appear 511 to offer the potential for a fast and cost-effective alternative to bioassay, and 512 will be proposed to the EURL Strain Typing Expert Group as a useful addition 513 to the panel of tests currently used for the screening of unknown isolates. 4 Classical scrapie field case characterised at APHA (Scrapie 19 [35] ) The designation 1-4-7 indicates a lesion profile in RIII mouse bioassay with peaks in areas 1,4 and 7, the same as seen with BSE isolates. 5 Atypical scrapie field case (UK active surveillance) characterised and titrated (10 6.92 LD50/gr) at APHA (unpublished data) Molecular mass of the unglycosylated band of a classical 3-band pattern b.
Three band pattern associated with classical scrapie and BSE. c.
Sample too weak to determine the banding pattern 
